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Abstract 
Background: Disclosure of the use of complementary health approaches (CHA) is an 
important yet understudied health behaviour with important implications for patient care. Yet 
research into disclosure of CHA has been atheoretical and neglected the role of health beliefs.  
Purpose: Using a consumer commitment model of CHA use as a guiding conceptual 
framework, the current study tests the hypotheses that perceived positive CHA outcomes 
(utilitarian values) and positive CHA beliefs (symbolic values) are associated with disclosure 
of CHA to conventional-care providers in a nationally representative US sample.  
Methods:  From a sample of 33,594 with CHA use information from the 2012 National 
Health Interview Survey (NHIS), a subsample of 7,348 who used CHA within the past 12 
months was analysed. The 2012 NHIS is a cross-sectional survey of the non-institutionalized 
US adult population, which includes the most recent nationally representative CHA use data.   
Results:  The 63.2 % who disclosed CHA use were older, less educated, and had visited a 
health-care provider in the past year. Weighted logistic regression analyses controlling for 
demographic variables revealed that those who disclosed were more likely to report 
experiencing positive psychological (improved coping and well-being) and physical 
outcomes (better sleep, improved health) from CHA, and hold positive CHA-related beliefs.  
Conclusions: CHA users who perceive physical and psychological benefits from CHA use, 
and who hold positive attitudes towards CHA are more likely to disclose their CHA use. 
Findings support the relevance of a consumer commitment perspective for understanding 
CHA disclosure, and suggest CHA disclosure as an important proactive health behaviour that 
warrants further attention. 
Key Words: Disclosure; complementary health approaches; health behaviours; health 
beliefs; patient-reported outcomes; consumer behaviour 
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Consisting of a broad and diverse set of healing therapies of differing modalities, 
practices, and health systems (1), complementary health approaches (CHA; formerly known 
as complementary and alternative medicine or “CAM”) are popular health-care options, with 
an increasing number of health-care consumers integrating CHA into their health-care 
repertoire. Whether defined as provider delivered (e.g., acupuncture, homeopathy, massage 
therapy), or as self-care (e.g., herbal supplements, yoga, meditation), rates of CHA use have 
been on the rise for more than a decade (2-4). For example, in 2012 over one-third of the US 
population had used some form of CHA in the previous year (4).   
Given the popularity of CHA, and evidence indicating CHA are primarily used to 
supplement rather than replace conventional health care (5-7), disclosure of CHA use to 
health-care providers is crucial for ensuring coordination of care (8), for minimizing any 
potential adverse reactions between CHA and conventional treatments (9, 10), and for 
improving adherence to treatment (e.g., 11). Disclosing CHA use can also facilitate better 
integration of CHA into both conventional care treatments and self-care. This may potentially 
improve the practice of important health behaviours, as there is evidence that CHA are 
associated with and may promote such behaviours (12-15). Despite the importance of CHA 
disclosure for safe and effective coordination of care, rates of disclosure to conventional care 
providers are not uniformly high, and can vary greatly across and within different 
populations. For example, rates of disclosure range from  21 to 71 % in general medical 
populations (16, 17),  from 12 to 53 % in oncology patients (18, 19), and are as low as 36 % 
in HIV patients (20), and 30 % in hypertension patients (11).  
Disclosure of CHA use is an important yet understudied health behaviour that can have 
several important implications for patient behaviors and care, as noted above. Understanding 
the factors that can facilitate disclosure of CHA use can help to guide educational strategies 
for both CHA users and conventional health-care providers, as well as inform clinical 
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guideline practices. Yet to date, the research on CHA disclosure has been largely atheoretical 
and focused on barriers to disclosure, such as poor patient-provider communication (17, 20-
22), rather than on factors that might promote or facilitate disclosure of CHA use, such as 
beliefs and outcomes from CHA use. The aim of this study was to address this gap by 
applying recent theoretical developments on CHA-related behaviours to understand the 
implicit reasons for disclosure of CHA use using a large, nationally representative sample. 
Understanding CHA Disclosure: Issues and Prospects 
There are several issues in the research to date on why people disclose their CHA use. 
First, research has been largely atheoretical and focused primarily on medical and 
socioeconomic factors as determinants, rather than on the underlying motivational factors for 
disclosure. For example, one national study (23) found people were more likely to disclose 
their CHA use if they were insured, treating a specific medical issue, or were referred to CHA 
by a health professional. Although these factors may contribute to the necessary conditions 
for disclosure, they do not necessarily reflect the reasons why people disclose their CHA use. 
Indeed, qualitative research indicates that the decision to disclose CHA use is often complex 
and involves not only objective medical and sociodemographic factors, but also subjective 
patient perspectives and beliefs about the costs and benefits of disclosure (24, 25).   
Second, research has tended to ignore the implicit reasons for disclosure, that is, how 
CHA disclosure may reflect unspoken patient values and beliefs. Such values and beliefs may 
be part of a broader system of beliefs relating to identity, and that are not necessarily 
explicitly linked to CHA disclosure. The notion that identity related factors may play a role in 
CHA disclosure is consistent with research on disclosure behavior in general within medical 
contexts. For example, research has demonstrated that the more important a particular 
identity is to an individual, the more likely they are to disclose identity-related information to 
general practitioners (26). Accordingly, disclosing CHA use to a health-care provider may be 
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viewed as a symbolic act that reinforces one’s identity with respect to being someone who 
uses CHA. Health beliefs and values are well-known to play a key role in health behaviors in 
general (27), and in other CHA-related behaviors such as the frequency and breadth of CHA 
use (5, 28). However, a scan of the published literature indicates that the link between CHA-
related beliefs and CHA disclosure has received little attention. In one of the two retrieved 
studies testing this link, attitude towards the benefits of CHA use was a predictor of 
disclosure of use of natural health products in a sample of 257 outpatients (29). In the other 
study, perceived control over health, experiencing positive health behavior outcomes from 
CHA, and patient-centered care, were associated with disclosure of provider-based CHA in a 
sample of 226 undergraduate students, but not in a sample of 126 adults from the community 
(25). The use of small non-representative convenience samples, and the focus on specific 
types of CHA, call into question the generalizability of these findings.  
The Consumer Commitment Model and Disclosure of CHA Use 
One model that holds some promise for addressing these issues and providing insights 
into how CHA values and beliefs are implicated in CHA disclosure behaviour, is the CAM 
consumer commitment model (30)(see Figure 1). Derived from extant research on the reasons 
why people continue to use CHA (5, 31, 32), consumer psychology (33) and health behavior 
theory (27, 34), the CAM consumer commitment model posits that commitment to CHA 
reflects a psychological state with behavioral indicators (30).  According to this model, 
disclosing CHA use to conventional health-care providers is one of several key CHA-related 
behaviours that reflect a commitment to continued use of CHA as a health-care option (25, 
30). These include using CHA frequently (5, 32, 35), recommending CHA to others, and 
adhering to CHA recommendations. 
The CAM consumer commitment model (30) is founded on principles of brand 
commitment from consumer psychology (33), and posits that CAM use as a health-care 
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choice, has similarities to brand choice among consumers.  Brand commitment or the degree 
to which a “consumer is emotionally attached to the relationship with a particular brand in a 
product class” (33), arises from value congruency and affective commitment, two related 
psychological constructs. Extending this model to CHA use, the CAM consumer commitment 
model posits that two sets of consumer values contribute to the development of commitment 
to CHA as a “brand” of health care. Utilitarian values reflect the functional benefits of CHA, 
which are that people will be motivated to commit to CHA use if they obtain positive 
outcomes from CHA, are satisfied with their CHA care, and trust CHA as a treatment option 
(30). These positive physical, emotional, and behavioral outcomes from CHA treatment are 
posited to play a role in commitment by reinforcing peoples’ decision to use CHA. In this 
respect, the positive CHA outcome strengthen utilitarian values in a manner similar to 
reciprocal determinism from Bandura’s (34) Social Cognitive Theory. To the extent that 
disclosure of CHA use is an indicator of CHA commitment, individuals will be more likely to 
disclose their use of CHA to conventional health-care providers if they experience positive 
outcomes from CHA use.  
In contrast, symbolic values reflect a meaningful “fit” or congruency between the 
individual’s beliefs about healing and CHA as a health-care option. Consistent with a 
systematic review of the health beliefs associated with CHA use (28), those who believe that 
CHA is a natural treatment option, promotes taking an active role in treatment and exercising 
control over one’s health, and emphasizes whole person treatment, are more likely to 
continue to use CHA because using CHA reinforces their health beliefs (30). In this respect, 
the CAM commitment model shares some of the underlying principles of other widely used 
and well-validated models of motivated health behavior, such as the Theory of Planned 
Behavior (TPB; 27). In the TPB positive beliefs about the behavior (pro-CHA beliefs) are the 
antecedents of intentions to engage in the behavior (CHA disclosure) and the actual behavior. 
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The notion that symbolic values are linked to CHA disclosure is also consistent with research 
demonstrating that coordination of care among different health-care providers is viewed as a 
meaningful act by health-care consumers (8), and with Lupton’s (36) assertion that health- 
care decisions include considerations of not only the “use” or practical value of health care, 
but also its abstract or symbolic value. Accordingly, we argue that these utilitarian and 
symbolic values can be viewed as the implicit reasons for CHA disclosure. 
Preliminary evidence supports the relevance of the CAM consumer commitment model 
(30) for understanding CHA disclosure. In a sample of undergraduate students and a sample 
of community adults, select symbolic (taking an active role in treatment decisions) and 
utilitarian (positive CHA outcomes) values were associated with a greater likelihood of 
disclosing the use of provider-delivered CHA to conventional health-care providers (25). 
However, the samples were small and non-representative, CHA use was provider-based only, 
and a limited set of values from the CAM consumer commitment model were examined. It is 
unknown whether the same results would be obtained with a larger, nationally representative 
sample, with a greater range of utilitarian and symbolic values, or in relation to both 
provider-based and self-care CHA.  
The Present Study 
The aim of this study was to address these issues by examining the role of utilitarian 
and symbolic values in CHA disclosure in the most recent representative US national data 
from the 2012 National Health Interview Survey (NHIS). Unique to the 2012 panel of the 
NHIS is the inclusion of a detailed set of subjective, patient-reported outcomes and beliefs 
about CHA use that is consistent with previous research, and that map onto the utilitarian and 
symbolic values from the CAM consumer commitment model adapted for explaining CHA 
disclosure (see Figure 2). The utilitarian values examined included positive psychological and 
physical outcomes experienced from CHA use, whereas the symbolic values included 
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positive beliefs about CHA that previous research indicates reflect a “fit” between CHA and 
the consumer (6, 28, 37). 
Based on the CAM consumer commitment model (30) and previous research applying 
this model to CHA disclosure (25), we hypothesized that utilitarian and symbolic values 
would predict disclosure of CHA use after accounting for relevant socio-demographic 
variables. Specifically, we controlled for a set of factors known to influence disclosure of 
CHA use, namely age, sex, ethnicity, income, marital status and education (21, 23, 38, 39) in 
the multivariate analysis of each consumer value. We also examined overall CHA use and the 
demographic characteristics associated with CHA use to contextualize the main analysis.  
Methods 
Study Design and Survey 
 The data are from the 2012 NHIS which includes the most recent data on CHA in the 
US. The NHIS is an ongoing multipurpose health survey of civilian, non-institutionalized 
population of the US (40). It is a multistage probability design and is a cross-sectional 
household interview survey. The survey includes a core component and, every five years, a 
supplement on Adult Alternative Medicine. A sample of adults from the core (Sample Adult 
Core) 18 or over from each household was randomly selected to respond to more detailed 
health questions and to participate in the Adult Alternative Medicine Supplement. In the 2012 
NHIS survey, n = 34,525 individuals were in the Sample Adult Core and the response rate 
was 79.7% (41). Adults were asked about their use of 20 specific CHA modalities. For those 
modalities used in the past 12 months, more detailed questions were asked included 
disclosure to a conventional health-care provider, reasons for use, and perceived health 
outcomes from using specific CHA modalities. 
Of the total sample (n = 34,525), 11,516 respondents indicated that they had used at 
least one CHA in the past 12 months. Further, 7,493 of these individuals reported having a 
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personal health-care provider and named at least one CHA as a top three CHA used for their 
health. Excluded individuals had an invalid or missing response for the question about a 
personal health-care provider (n = 1,582), did not have a personal health-care provider nor 
mentioned a top three CHA (n = 223), had a personal health-care provider but did not 
mention a top 3 CHA (n = 890), or indicated a top three CHA but did not have a personal 
health-care provider (n = 1,328). In addition, the answer to the question about disclosure was 
missing, “refused”, “don’t know”, or “not ascertained” for 145 respondents, resulting in a 
final sample of 7,348 individuals. 
Our analytic sample first considers all those individuals with valid CHA use 
information (n = 33,594), but the focus is on recent CHA users who have a personal health-
care provider, and with valid information on disclosure, reasons for use, and health outcomes 
(n = 7,348). Table 1 presents the demographic characteristics of both the overall sample and 
the CHA user subsample. 
Table 1 
Measures  
 CHA use in past 12 months. The NHIS includes questions regarding use of 20 
different CHA, making this array of CHA among the most comprehensive available in 
national US datasets. Individuals who reported use of at least one type of CHA (e.g., 
acupuncture, meditation, yoga, chiropractic, among others) in the past 12 months were coded 
as “recent users” (see Table 2 for a full list of the CHA types used). 
 Disclosure to conventional provider. For up to three of the CHA modalities used in 
the past 12 months, individuals who used CHA within the past 12 months and had a regular 
health-care provider were asked if they “let your personal health-care provider know about 
your use of [CHA modality]”? A response of “yes” for any CHA modality was counted as 
indicating disclosure of CHA. In the NHIS, personal health-care provider is defined as “a 
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health professional who knows you well and is familiar with your health history. This can be 
a general doctor, a specialist doctor, a nurse practitioner, a physician’s assistant, or another 
type of provider.”  
 Utilitarian and symbolic values for CHA use. Unique to the 2012 Adult Alternative 
Medicine supplement is the inclusion of an array of questions regarding reasons for CHA use 
and perceived health benefits of use. We incorporated some of these measures to 
operationalize our two key constructs. Utilitarian values were based on users’ reports that 
CHA did the following: 1) reduced stress, 2) improved sleep, 3) made them feel better 
emotionally, 4) made it easier to cope with health problems, and 5) improved overall health 
and made them feel better overall. Any mention of each health benefit was coded as a “yes.” 
Symbolic values included: 1) CHA gave user a sense of control over own health, 2) CHA can 
be done on own, 3) CHA is natural, and 4) CHA focuses on the whole person, mind, body, 
and spirit. Any mention of each reason for CHA use was coded as a “yes.” Each of these 
dichotomous variables is treated as a predictor to investigate the association of perceived 
health benefits (utilitarian values) and attitudes about CHA (symbolic values), with 
disclosure.  
 Covariates. Gender was coded as a dichotomous variable. Age was coded as an 
ordinal variable (18-29, 30-39, 40-49, 50-59, 60-69, 70+). Race and ethnicity was based on 
self-report with priority given to any mention of Hispanic, with the White, Black, Asian, and 
Other race categories referring to non-Hispanic. Education was coded ordinally (less than 
high school, high school or GED graduate, some college but no degree, associate degree, 
college graduate, and more than college graduate). Annual household income was coded into 
the following categories (< $34,999, $35,000-$49,999, $50,000-$74,999, $75,000-$99,999, 
and >$100,000). Marital status was coded as a categorical variable (never married, married, 
cohabiting, and divorced/widowed). Nativity status was coded as a categorical variable (US 
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born and foreign born). Lastly, whether a health-care provider had been visited in the past 12 
months was coded dichotomously (yes versus no). 
Table 2 
Analyses 
 All analyses were weighted and used the sample adult sampling weights and estimates 
are representative of the non-institutionalized US population 18 and over (41). Bivariate 
analyses used the design-based F test, a corrected weighted Pearson chi-square statistic 
converted to a F statistic. Weighted logistic regression was used to first examine the 
demographic correlates of disclosure among CHA users in 9 separate regressions, one for 
each of the utilitarian (5) and symbolic (4) values being tested. Then, among CHA users, we 
investigated the association between each of the utilitarian and symbolic values and 
disclosure. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) of the AOR are 
presented. All analyses were performed using Stata 12.0 (42).  
Results 
 Table 1 shows the prevalence of CHA use in the past 12 months according to 
demographic characteristics. Overall, over 35.5% of American adults used CHA and there 
were significant differences in use for all demographic characteristics. A higher percentage of 
women used CHA compared to men and while there were significant age differences in CHA 
use, the actual prevalence was not all that different according to age, although the oldest age 
group had the lowest use. Whites, Asians, and Other racial groups all had higher (and similar) 
prevalence of use compared to Blacks and Hispanics. Prevalence of CHA use was 
significantly higher among those with higher education and higher incomes. CHA use also 
differed significantly according to nativity status, with higher CHA use among those who 
were US born. While there were significant differences according to marital status, the actual 
percentages were fairly similar. Last, among adults who used CHA in the past 12 months and 
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also reported they had a health-care provider, nearly two-thirds disclosed their use of CHA to 
their provider (63.2%). 
 The remaining analyses only considers CHA users who provided information on their 
disclosure (n = 7,348). First, to better understand how CHA disclosure varied across different 
types of CHA, the CHA were categorised according to whether they were provider-delivered 
(e.g., acupuncture, energy healing etc.), products (e.g., herbs, natural supplements, etc.), or 
practices (e.g., yoga, meditation, etc.) according to the definitions from Upchurch and 
Wexler-Rainsich (13). Because respondents could mention up to three CHA used in the past 
year, categories were not mutually exclusive. For the 4,212 category mentions of using CHA 
providers, 54.87 % were disclosed. For the 4,295 category mentions of using CHA products, 
72.92 % were disclosed. Finally, for the 3,771 category mentions of using CHA practices, 
45.45 % were disclosed. 
Table 3 presents the multivariate results with respect to demographic characteristics 
associated with disclosure. There were no gender differences. Compared to the youngest age 
group, all older ages were significantly more likely to disclose and the adjusted odds ratios 
were greater as age increased. For example, for 30-39 year olds the AOR was 1.39 but for 
those 70 and older it was 3.37. Except for those with an Associate Degree, those with more 
education were less likely to disclose compared to those with the lowest level of education. 
Those who had visited their health-care provider in the previous 12 months were also more 
likely to disclose their CHA use. There were no significant differences in disclosure for 
income, race/ethnicity, nativity status, or marital status. 
Table 3 
 Table 4 presents the results for a series of regression analyses examining the 
association between disclosure and individual utilitarian (practical) and symbolic values. The 
first column shows the weighted percentages of CHA users who reported “yes” to each of the 
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nine items for at least one of the top 3 CHA. Close to or more than half of recent CHA users 
reported positive health outcomes (utilitarian values) and expressed holistic and empowering 
attitudes about CHA (symbolic values). For example, over three-quarters of users said CHA 
improved their overall health and made them feel better, and almost two-thirds used CHA 
because they thought it was natural. 
Table 4 
 In the multivariate models, all utilitarian value (except for reduced stress), and all 
symbolic values, were significantly associated with disclosure of CHA use. With respect to 
utilitarian values, those who reported better sleep, feeling better emotionally, increased ability 
to cope with health problems, and improved overall health and feeling better, were more 
likely to disclose CHA use to their health-care provider. With respect to symbolic values, 
those who reported that they used CHA because it gave them more control over their health, 
because it afforded them a more active role in their health, and because CHA is natural and 
focuses on the whole person, were more likely to disclose their CHA use. 
Table 3 
Discussion 
Using the CAM consumer commitment model (30) as a guiding conceptual 
framework, we found support for our hypotheses regarding the role of health-related beliefs 
and positive CHA outcomes in the disclosure of CHA use to conventional health-care 
providers. Those who experienced positive psychological and physical outcomes from CHA 
(utilitarian values), and who held positive beliefs about CHA (symbolic values) were more 
likely to disclose CHA use to health-care providers. Importantly, four out of the five 
utilitarian values, and all four of the symbolic values, tested were significantly associated 
with CHA disclosure after accounting for relevant socio-demographic variables. Overall, 
these findings extend previous research with small non-representative samples (25) by 
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demonstrating for the first time that the CAM consumer model of commitment is relevant for 
understanding CHA disclosure in a large nationally representative sample of CHA users.  
Our results with respect to demographic factors were generally consistent with 
previous research.  The likelihood of disclosing CHA use associated with older ages has been 
noted in other studies of both general medical and clinical samples (20, 23, 38). Additionally, 
previous research has found that lower levels or education were associated with greater 
likelihood of CHA disclosure (21, 39). However, unlike our findings, in an analysis of 2002 
NHIS, CHA disclosure rates were higher among non-Latino whites relative to other 
racial/ethnic groups (21), while we found no racial/ethnic differences in disclosure. This may 
be due to differences in model specifications or time trend differences in racial/ethnic 
disclosure rates, as the data we used were collected in 2012.  
Our findings have important implications for public health concerns and conventional 
care issues with respect to the non-disclosed use of CHA in relation to conventional 
medicine. We found that 35.5 % of American adults had used some form of CHA in the 
previous 12 months, and that 63.2 % of these CHA users who had a health-care provider, had 
disclosed their use of CHA. These results highlight both the continued prevalence of CHA 
use and that disclosure remains an important issue to understand and address. The findings 
provide supportive evidence for the proposition that positive experiences and beliefs about 
CHA are linked to disclosure of CHA use because disclosure reflects an ongoing 
commitment to using CHA as part of one’s health-care repertoire (30). Although a similar 
linkage between the positive benefits of CHA (in the form of natural products use) and 
disclosure has been noted in previous research (29), the reasons for this association were not 
discussed. Our study addresses this issue by situating CHA disclosure within the theoretical 
context of commitment to CHA. 
The results with respect to the associations of symbolic values with CHA disclosure also 
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provide new insights into disclosure as a health behaviour. Those who believed CHA 
promotes taking an active role and gives a sense of control over health were more likely to 
disclose their CHA. This provides suggestive evidence that disclosure of CHA may also be 
viewed as a proactive means of taking control of health by patients.  Though speculative, this 
assertion is consistent with evidence indicating that disclosure of CHA use is associated with 
engaging in disease self-management behaviours (20). It is also consistent with previous 
research indicating that individuals who use CHA are proactive health-care consumers who 
value control and autonomy over their health (28, 37). Accordingly, they are more likely to 
engage in positive health behaviours such as physical activity and healthy eating (12, 43), use 
preventive health services (44, 45), and are less likely to engage in health risky behaviours 
such as smoking (12), in comparison to those who do not use CHA. In this respect, disclosure 
of CHA may be considered an important health behaviour akin to other health-promoting and 
self-care behaviours, and which deserves greater attention in both research and clinical 
settings.  
The current findings also draw attention to the perceived benefits of CHA use in the US 
population in relation to CHA disclosure. Over three-quarters of CHA users reported that 
CHA improved their overall health, and over 40 % reported specific psychological and 
physical benefits from CHA including improved sleep, better coping, improved emotional 
well-being, and stress management. The endorsement of utilitarian values appears to reflect 
the use of CHA for health self-management and wellness purposes rather than strictly 
therapeutic purposes, a growing trend noted in previous research (13). When such use is 
perceived to be effective, our findings indicate that users are more likely to disclose their 
CHA use to health-care providers. 
Additional implications of these results centre on a corollary of these findings. Those 
who did not experience beneficial physical and psychological outcomes from CHA, and who 
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were less invested in beliefs and values reflecting an acceptance of, and commitment to, 
CHA, were less likely to disclose their CHA use.  The former proposition, in particular, 
suggests that some users may not feel it necessary, or may feel embarrassed, to tell their 
health-care providers about CHA use if CHA was not effective for improving their health and 
well-being.  
For such individuals, it is also possible that CHA may not be appropriate for dealing 
with specific health concerns and thus did not yield beneficial results. Additionally, CHA 
may have even contributed to adverse effects resulting from the CHA treatment itself, or 
from the context in which the treatment was delivered (46).  Under these circumstances, CHA 
use may have been dismissed as not worth mentioning to the health-care provider simply 
because it didn’t work, or because they had discontinued CHA use and thus did not feel it 
necessary to disclose. From a CAM consumer commitment perspective, individuals who are 
less committed to CHA use (perhaps because they do not experience psychological and 
physical benefits from CHA), and who use CHA less frequently or on a trial rather than 
ongoing basis, may be less likely to disclose this use to their conventional care providers. 
These individuals may be at greater risk for experiencing adverse interactions between CHA 
and conventional care because of lost opportunities to optimize continuity in the delivery of 
their care.  
The finding that CHA consumers who have more positive outcomes are more likely to 
disclose CHA use has potential important implications for general practitioners (GPs) and 
their patients. Qualitative evidence suggests that GPs gain some of their knowledge about 
CHA directly from their patients’ experiences, and that such experiential knowledge plays a 
key role in advising patients about CHA use (47). Thus, it is important that GPs are aware 
that the information they get about CHA from patients who do disclose their use will be 
biased towards positive results from CHA. The current study suggests that that those with 
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less positive results will be less likely to share their use or this information with GPs. 
The findings from the current study should be considered in light of several limitations 
and strengths. The cross-sectional design of the NHIS precludes drawing any firm 
conclusions about the causal relations or temporal order of the utilitarian and symbolic values 
in relation to CHA disclosure. The analysis excluded participants who did not specify 
whether they had personal health-care provider and those who had not used CHA within the 
past 12 months. There is some evidence that “infrequent” CHA consumers hold different 
beliefs about CHA than more frequent consumers (5), suggesting that the current findings 
may not generalise to this group of CHA consumers.  In addition, participants were simply 
asked about whether or not they disclosed CHA, and not about the details and contexts in 
which disclosure occurred. Therefore, in this study it is unknown whether disclosure was 
patient initiated or provider initiated, or how positive CHA experiences and beliefs about 
CHA may be related to each type of disclosure. Indeed, there is evidence that CHA use is not 
likely to be disclosed if the provider doesn’t initiate the discussion (22). Accordingly, future 
work on CHA disclosure behaviour should take a more fine-grained approach to assessing the 
circumstances surrounding CHA disclosure, and employ a longitudinal approach to test the 
temporal precedence of CHA values in relation to disclosure suggested by the CAM 
consumer commitment model (30).  
Despite these limitations, the use of a large nationally representative sample of CHA 
consumers is a clear strength of the study that provides greater confidence in the findings and 
their generalizability and strong evidence supporting the use of the CAM consumer model for 
understanding CHA disclosure. Our findings also provide good preliminary evidence that 
reframing CHA disclosure as a proactive health behaviour rather than simply as a patient-
provider communication issue can provide useful insights into the factors that facilitate 
disclosure.  Understanding how CHA disclosure may relate to other important preventive and 
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health-promoting behaviours, such as screening behaviours, diet, and physical activity, could 
also be a fruitful area for future research. 
Conclusions 
 By taking a theory-driven approach to understanding CHA disclosure, our study is the 
first to find support for the role of health-related consumer values and patient outcomes for 
disclosure in a large nationally representative sample of US adults. CHA users who 
experience physical and psychological benefits from CHA use, and who hold positive 
attitudes towards CHA, are more likely to disclose their CHA use to conventional care 
providers. We argue that these findings can be understood from the perspective of consumer 
commitment to CAM (30), and that disclosure of CHA use can be conceptualised as a 
behavioural indicator of being psychologically committed to using CHA as a health-care 
option, that reflects taking an active role in coordinating CHA care with conventional 
providers. Further research is needed to build on these findings and longitudinally examine 
the role of positive CHA outcomes and beliefs in CHA disclosure behaviour.  
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Figure 1:  Complementary and Alternative Medicine (CAM) Consumer Commitment Model 
(Sirois, Salamonsen, & Kristoffersen, 2016). 
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Figure 2: Consumer Commitment model of Complementary Health Approaches (CHA) 
disclosure. Adapted from Sirois, Salamonsen, & Kristoffersen (2016). Reasons for continuing 
use of Complementary and Alternative Medicine (CAM) in students: a consumer 
commitment model. BMC Complementary and Alternative Medicine, 16(1), 1-9. 
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Table 1. Demographic Characteristics and Prevalence of Complementary Health 
Approaches (CHA) Use in Past Year, US Adults, NHIS 2012 (N =33,594)a 
 Total (%) CAM users 
(%) 
Design-
based F-test 
p-value 
Total 100.0
  
35.5   
Gender     
  Men 45.3 30.9 182.8 0.000 
  Women 54.7 39.3   
Age***     
  18-29 19.2 33.5 32.6 0.000 
  30-39 16.5 38.1   
  40-49 16.4 37.3   
  50-59 17.6 38.7   
  60-69 15.1 38.0   
  >70 15.2 27.0   
Race/Ethnicity     
  White 69.4 39.7 152.1 0.000 
  Black 12.5 22.3   
  Hispanic 12.8 24.2   
  Asian 4.5 39.3   
  Other 0.8 39.3   
Education      
  < High School 13.6 16.4 278.4 0.000 
  High School Graduate 25.9 26.4   
  Some college, No  degree 20.4 38.0   
  Associate Degree 10.9 40.7   
  College Graduate 18.8 46.3   
  >College 10.4 53.1   
Household Income    117.1 0.000 
  <$34,999 43.1 28.2   
  $35,000-$49,999 13.4 34.0   
  $50,000-$74,999 17.2 39.5   
  $75,000-$99,999 9.8 42.1   
  >$100,000 16.5 46.8   
Marital Status     
  Never Married 24.2 34.9 5.5 0.001 
  Married 43.8 36.8   
  Cohabiting 6.0 36.3   
  Divorced/Widowed 26.0 33.7   
Nativity Status     
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  US born 84.5 36.9 123.9 0.000 
  Foreign born 15.5 27.7   
Disclosure (N=7,493)b -- 63.2   
a All percentages weighted to US population estimates. b Among those reporting 
CHA use in past year and reported having a healthcare provider.  
 
  
30 
 
Table 2 
Complementary and alternative health approaches (CHA) included the use of one or more of 
the following during the past 12 months. CHA are categorized according to Upchurch and 
Wexler-Rainsich (13). 
Providers Products Practices 
1. acupuncture 
2. Ayurveda 
3. biofeedback 
4. chelation therapy  
5. chiropractic/osteopathic 
6. energy healing therapy 
7. hypnosis 
8. massage 
9. naturopathy 
10. homeopathic treatment 
11. folk medicine or 
traditional healers 
 
12. nonvitamin, nonmineral 
(NVNM) dietary 
supplements  
 
13. Yoga 
14. tai chi 
15. qi gong 
16. meditation 
17. guided imagery 
18. progressive relaxation 
19. deep breathing 
20. special diets (including 
vegetarian and vegan, 
macrobiotic, Atkins, 
Pritikin, and Ornish) 
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Table 3. Weighted Logistic Regression of Complementary Health Approaches (CHA)  Disclosure 
on Demographic variables, Among US Adult CHA Users, NHIS 2012 (N=7,348)a 
 Adjusted Odds 
Ratio 
95% CI 
Gender   
  Men 1.00 -- 
  Women 0.98 (0.87, 1.10) 
Age   
  18-29 1.00 -- 
  30-39 1.39** (1.12, 1.72) 
  40-49 1.79*** (1.41, 2.29) 
  50-59 2.17*** (1.72, 2.74) 
  60-69 2.89*** (2.25, 3.73) 
  >70 3.37*** (2.59, 4.39) 
Race/Ethnicity   
  White 1.00 -- 
  Black 1.04 (0.85, 1.27) 
  Hispanic 0.83 (0.66, 1.05) 
  Asian 0.76 (0.57, 1.02) 
  Other 1.14 (0.62, 2.09) 
Education    
  < High School 1.00 -- 
  High School Graduate 0.69** (0.54, 0.91) 
  Some college, No degree 0.67** (0.52, 0.86) 
  Associate Degree 0.84 (0.65, 1.09) 
  College Graduate 0.66** (0.51, 0.85) 
  >College 0.66** (0.50, 0.87) 
Household Income    
  <$34,999 1.00 -- 
  $35,000-$49,999 1.04 (0.85, 1.26) 
  $50,000-$74,999 0.99 (0.84, 1.19) 
  $75,000-$99,999 1.06 (0.85, 1.33) 
  >$100,000 0.91 (0.76, 1.10) 
Marital Status   
  Never Married 1.00 -- 
  Married 1.13 (0.95, 1.34) 
  Cohabiting 0.82 (0.63, 1.08) 
  Divorced/Widowed 1.04 (0.86, 1.25) 
Nativity   
   US born 1.00 -- 
   Foreign born 0.98 (0.79, 1.22) 
Provider visit in last 12 mo   
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   no 1.00 -- 
   yes 3.67*** (2.77, 4.85) 
a Among those reporting use of CHA in past year and reported having a healthcare provider. 
*p<.05; **p<.01; ***p<.001. 
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Table 4. Weighted Logistic Regression of Disclosure on Utilitarian and Symbolic Values, 
Among US Adult Complementary Health Approach (CHA) Users, NHIS 2012 (N=7,348)a 
 
 Percentage 
Responding 
Yes (%) 
Adjusted 
Odds Ratio 
95% Confidence 
Interval 
Utilitarian Values    
Reduced stress 57.8 0.95 (0.83, 1.08) 
Better sleep 46.7 1.27*** (1.12, 1.44) 
Feeling better emotionally 48.1 1.16* (1.03, 1.30) 
Easier to cope with health problems 42.8 1.81***  (1.61, 2.03) 
    Improved overall health 75.7 1.68*** (1.48, 1.90) 
Symbolic Values    
Gave sense of control over health  49.1 1.70*** (1.51, 1.91) 
Can use CAM on my own 53.4 1.58*** (1.41, 1.78) 
CAM is natural 62.4 1.62*** (1.44, 1.83) 
CAM focuses on whole person 46.6 1.16* (1.04, 1.30) 
a Those reporting CHA use in past year and reported having a health-care provider. Results 
are for 9 separate regressions. Covariates included gender, age, race/ethnicity, education, 
income, and marital status. Confidence intervals that are less than 1 are non-significant. 
*
 p<0.05 
***
 p<0.001 
 
 
 
